Gilead Sciences (NasdaqGS:GILD) announced positive data regarding Livdelzi for PBC and bulevirtide for chronic HDV, underscoring progress in liver disease treatment. During the last quarter, the ...

With our personalized horoscope, you’ll get the insights you need to take action and enjoy your day with confidence.My free daily horoscopeYour daily horoscope will give you an insight into the day's ...